HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Min Tang Selected Research

Membrane Proteins (Integral Membrane Proteins)

12/2021Conformational change of adenine nucleotide translocase-1 mediates cisplatin resistance induced by EBV-LMP1.
9/2021()-Epigallocatechin-3-Gallate Inhibits EBV Lytic Replication via Targeting LMP1-Mediated MAPK Signal Axes.
1/2020Drp1-dependent remodeling of mitochondrial morphology triggered by EBV-LMP1 increases cisplatin resistance.
1/2020Wild-type IDH2 contributes to Epstein-Barr virus-dependent metabolic alterations and tumorigenesis.
1/2018(-)-Epigallocatechin-3-gallate inhibition of Epstein-Barr virus spontaneous lytic infection involves downregulation of latent membrane protein 1.
1/2013Tyrosylprotein sulfotransferase-1 and tyrosine sulfation of chemokine receptor 4 are induced by Epstein-Barr virus encoded latent membrane protein 1 and associated with the metastatic potential of human nasopharyngeal carcinoma.
6/2012Epstein-Barr virus-encoded LMP1 triggers regulation of the ERK-mediated Op18/stathmin signaling pathway in association with cell cycle.
1/2011Down-regulation of EBV-LMP1 radio-sensitizes nasal pharyngeal carcinoma cells via NF-κB regulated ATM expression.
7/2008DNAzymes targeted to EBV-encoded latent membrane protein-1 induce apoptosis and enhance radiosensitivity in nasopharyngeal carcinoma.
3/2008The activation of p53 mediated by Epstein-Barr virus latent membrane protein 1 in SV40 large T-antigen transformed cells.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Min Tang Research Topics

Disease

98Neoplasms (Cancer)
09/2022 - 10/2004
31Nasopharyngeal Carcinoma
04/2022 - 05/2002
17Atrial Fibrillation
01/2022 - 12/2006
16Carcinogenesis
05/2022 - 07/2005
15Neoplasm Metastasis (Metastasis)
01/2022 - 11/2011
13Inflammation (Inflammations)
04/2022 - 01/2009
12Hepatocellular Carcinoma (Hepatoma)
01/2021 - 01/2008
11Infections
01/2022 - 10/2005
9Fibrosis (Cirrhosis)
09/2022 - 04/2008
8Colorectal Neoplasms (Colorectal Cancer)
06/2022 - 01/2013
8Prostatic Neoplasms (Prostate Cancer)
03/2022 - 06/2015
8Carcinoma (Carcinomatosis)
09/2018 - 11/2004
7Breast Neoplasms (Breast Cancer)
08/2022 - 11/2011
7Obesity
03/2022 - 08/2018
6Liver Cirrhosis (Hepatic Cirrhosis)
09/2022 - 11/2014
6Pain (Aches)
04/2019 - 09/2014
5Necrosis
09/2022 - 02/2010
5Lung Neoplasms (Lung Cancer)
12/2019 - 01/2015
5Renal Cell Carcinoma (Grawitz Tumor)
11/2019 - 06/2011
5Hypoxia (Hypoxemia)
01/2018 - 01/2009
4Glaucoma
01/2022 - 10/2011
4Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 03/2017
4Ischemia
05/2021 - 10/2009
4Stomach Neoplasms (Stomach Cancer)
02/2021 - 08/2017
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 01/2015
4Osteosarcoma (Osteogenic Sarcoma)
01/2021 - 10/2013
4Tachycardia (Tachyarrhythmias)
01/2020 - 12/2006
4Heart Arrest (Cardiac Arrest)
06/2012 - 01/2009
3Chronic Kidney Failure (Chronic Renal Failure)
07/2022 - 09/2008
3Non-alcoholic Fatty Liver Disease
03/2022 - 12/2020
3Hemorrhage
01/2022 - 01/2018
3Type 2 Diabetes Mellitus (MODY)
01/2022 - 08/2018
3Diabetic Retinopathy (Retinopathy, Diabetic)
01/2022 - 01/2019
3Melanoma (Melanoma, Malignant)
12/2021 - 11/2009
3Sepsis (Septicemia)
09/2021 - 10/2010
3Heart Failure
06/2021 - 11/2006
3Glioblastoma (Glioblastoma Multiforme)
02/2021 - 01/2017
3Mitral Valve Insufficiency (Mitral Regurgitation)
01/2021 - 04/2008
3Adenocarcinoma of Lung
01/2021 - 12/2019
3Myocardial Infarction
01/2021 - 11/2018
3Body Weight (Weight, Body)
01/2021 - 05/2014
3Alzheimer Disease (Alzheimer's Disease)
10/2020 - 10/2018
3Urinary Bladder Neoplasms (Bladder Cancer)
04/2018 - 12/2015

Drug/Important Bio-Agent (IBA)

41Proteins (Proteins, Gene)FDA Link
01/2022 - 10/2004
23Biomarkers (Surrogate Marker)IBA
01/2022 - 10/2009
19Membrane Proteins (Integral Membrane Proteins)IBA
12/2021 - 05/2002
12Messenger RNA (mRNA)IBA
09/2022 - 11/2004
12Pharmaceutical PreparationsIBA
07/2022 - 08/2015
8MicroRNAs (MicroRNA)IBA
03/2022 - 01/2008
8Biological ProductsIBA
12/2021 - 11/2011
7Oncogene Proteins (Oncogene Protein)IBA
01/2022 - 06/2003
7DNA (Deoxyribonucleic Acid)IBA
10/2020 - 03/2013
6Catalytic DNA (Deoxyribozyme)IBA
01/2018 - 07/2005
5Small Interfering RNA (siRNA)IBA
08/2022 - 02/2014
5LipidsIBA
08/2022 - 06/2013
5Cisplatin (Platino)FDA LinkGeneric
03/2022 - 06/2014
5Glucose (Dextrose)FDA LinkGeneric
01/2022 - 10/2009
5CytokinesIBA
01/2022 - 02/2010
5Indicators and Reagents (Reagents)IBA
01/2022 - 01/2018
5Long Noncoding RNAIBA
01/2021 - 01/2018
5Transcription Factors (Transcription Factor)IBA
01/2021 - 03/2008
5Immunoglobulins (Immunoglobulin)IBA
01/2016 - 11/2004
5Transcription Factor AP-1 (Transcription Factor AP 1)IBA
08/2013 - 06/2003
5NF-kappa B (NF-kB)IBA
10/2009 - 06/2003
4Reactive Oxygen Species (Oxygen Radicals)IBA
09/2022 - 10/2016
4EnzymesIBA
04/2022 - 10/2014
4ORALIT (ORS)IBA
01/2022 - 09/2014
4Hemoglobins (Hemoglobin)IBA
01/2022 - 11/2016
4AlbuminsIBA
01/2022 - 11/2016
4ErbB Receptors (EGF Receptor)IBA
01/2021 - 05/2002
4OsteopontinIBA
12/2020 - 12/2016
4Androgen Receptors (Androgen Receptor)IBA
01/2020 - 06/2015
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2017 - 01/2016
3Circular RNAIBA
05/2022 - 01/2020
3Fatty Acids (Saturated Fatty Acids)IBA
04/2022 - 01/2018
3Circulating Tumor DNAIBA
01/2022 - 10/2017
3IntegrinsIBA
01/2022 - 06/2018
3Retinaldehyde (Retinal)IBA
01/2022 - 01/2018
3Viral ProteinsIBA
12/2021 - 12/2011
3LigandsIBA
01/2021 - 12/2018
3RNA (Ribonucleic Acid)IBA
01/2021 - 10/2009
3Tyrosine Kinase InhibitorsIBA
01/2021 - 08/2011
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 02/2010
3AntioxidantsIBA
01/2020 - 10/2009
3CollagenIBA
01/2020 - 08/2015
3Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
01/2020 - 01/2017
3Therapeutic UsesIBA
04/2019 - 04/2017
3Protein Kinases (Protein Kinase)IBA
09/2018 - 02/2009
3Peptides (Polypeptides)IBA
01/2018 - 01/2011
3salicylhydroxamic acid (SHAM)IBA
01/2018 - 04/2008

Therapy/Procedure

32Therapeutics
04/2022 - 08/2008
11Drug Therapy (Chemotherapy)
06/2022 - 01/2013
8Catheter Ablation
01/2022 - 12/2007
7Radiotherapy
01/2022 - 10/2013
5Hepatectomy
12/2022 - 04/2016
5Radiofrequency Ablation
06/2016 - 06/2011
4Immunotherapy
12/2021 - 01/2020
3Castration
03/2022 - 01/2020
3Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
12/2020 - 06/2012
3Catheters
10/2020 - 11/2006